BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11933177)

  • 1. Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma.
    Chua DT; Sham JS; Wei WI; Ho WK; Au G; Choy D
    Head Neck; 2002 Apr; 24(4):350-60. PubMed ID: 11933177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience.
    Chua DT; Sham JS; Choy D; Kwong DL; Au GK; Kwong PW; Yau CC; Cheng AC; Wan KY
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1219-28. PubMed ID: 11286826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nodal status on determinants of initial treatment response and patterns of relapse-free survival in nasopharyngeal carcinoma.
    Tang SG; See LC; Chen WC; Tsang S; Chang JT; Hong JH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):867-73. PubMed ID: 10863054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
    Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
    J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.
    Chan AT; Teo PM; Ngan RK; Leung TW; Lau WH; Zee B; Leung SF; Cheung FY; Yeo W; Yiu HH; Yu KH; Chiu KW; Chan DT; Mok T; Yuen KT; Mo F; Lai M; Kwan WH; Choi P; Johnson PJ
    J Clin Oncol; 2002 Apr; 20(8):2038-44. PubMed ID: 11956263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
    Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.
    El-Weshi A; Khafaga Y; Allam A; Mosseri V; Ibrahim E; El-Serafi M; El-Badawi S
    Acta Oncol; 2001; 40(5):574-81. PubMed ID: 11669328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
    Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
    Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
    Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
    J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis.
    Chua DT; Sham JS; Au GK; Choy D
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):334-43. PubMed ID: 12023137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).
    Teo PM; Leung TW; Chan AT; Yu P; Lee WY; Leung SF; Kwan WH; Johnson P
    Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):373-9. PubMed ID: 8746267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
    Zhang B; Hu Y; Xiong RH; Pan YF; Xu QL; Kong XY; Cai R; Chen QQ; Tang HY; Jiang W
    Oncotarget; 2017 Feb; 8(8):14078-14088. PubMed ID: 27845907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
    ;
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):463-9. PubMed ID: 8655368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.
    Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T
    Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.